101 related articles for article (PubMed ID: 2824082)
1. DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection.
Lücke-Huhle C; Hinrichs S; Speit G
Carcinogenesis; 1987 Dec; 8(12):1801-6. PubMed ID: 2824082
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of two human cell lines with amplified dihydrofolate reductase genes.
Hahn P; Kapp LN; Painter RB
Exp Cell Res; 1987 Jan; 168(1):89-94. PubMed ID: 3023120
[TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility to carcinogen-induced amplification of SV40 and dhfr sequences in SV40-transformed human keratinocytes.
Rossman TG; Wolosin D
Mol Carcinog; 1992; 6(3):203-13. PubMed ID: 1332730
[TBL] [Abstract][Full Text] [Related]
4. Similarities between human ataxia fibroblasts and murine SCID cells: high sensitivity to gamma rays and high frequency of methotrexate-induced DHFR gene amplification, but normal radiosensitivity to densely ionizing alpha particles.
Lücke-Huhle C
Radiat Environ Biophys; 1994; 33(3):201-10. PubMed ID: 7809366
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced gene amplification in rodent and human cells.
Lücke-Huhle C; Gloss B; Herrlich P
Acta Biol Hung; 1990; 41(1-3):159-71. PubMed ID: 1965560
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate resistance in NIH3T3 cells expressing polyoma virus oncogenes.
Wani M; Snapka RM
Teratog Carcinog Mutagen; 1989; 9(6):369-82. PubMed ID: 2576816
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
Bürkle A; Heilbronn R; zur Hausen H
Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T
Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121
[TBL] [Abstract][Full Text] [Related]
9. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.
Srimatkandada S; Schweitzer BI; Moroson BA; Dube S; Bertino JR
J Biol Chem; 1989 Feb; 264(6):3524-8. PubMed ID: 2914962
[TBL] [Abstract][Full Text] [Related]
10. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
Wani MA; Xu X; Stambrook PJ
Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600
[TBL] [Abstract][Full Text] [Related]
11. Murine erythroleukemia cell variants: isolation of cells that have amplified the dihydrofolate reductase gene and retained the ability to be induced to differentiate.
Corin RE; Turner T; Szabo P
Biochemistry; 1986 Jul; 25(13):3768-73. PubMed ID: 3461851
[TBL] [Abstract][Full Text] [Related]
12. Selective overproduction of human dihydrofolate reductase in a methotrexate-resistant human-mouse somatic cell hybrid.
Sastry KJ; Chan TS; Rodriguez LV
Biochem Biophys Res Commun; 1985 Oct; 132(2):795-803. PubMed ID: 4062946
[TBL] [Abstract][Full Text] [Related]
13. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
Vinh DB; McIvor RS
J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc.
Denis N; Kitzis A; Kruh J; Dautry F; Corcos D
Oncogene; 1991 Aug; 6(8):1453-7. PubMed ID: 1886715
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
Sakai K
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
[TBL] [Abstract][Full Text] [Related]
16. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate].
Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA
Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154
[TBL] [Abstract][Full Text] [Related]
17. Permissivity for methotrexate-induced DHFR gene amplification correlates with the metastatic potential of rat adenocarcinoma cells.
Lücke-Huhle C
Carcinogenesis; 1994 Apr; 15(4):695-700. PubMed ID: 8149482
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification in a leukemic patient treated with methotrexate.
Horns RC; Dower WJ; Schimke RT
J Clin Oncol; 1984 Jan; 2(1):2-7. PubMed ID: 6583327
[TBL] [Abstract][Full Text] [Related]
19. Resistance to methotrexate due to gene amplification in a patient with acute leukemia.
Carman MD; Schornagel JH; Rivest RS; Srimatkandada S; Portlock CS; Duffy T; Bertino JR
J Clin Oncol; 1984 Jan; 2(1):16-20. PubMed ID: 6583326
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic hormones and tumor promoters greatly increase the incidence of colony-forming cells bearing amplified dihydrofolate reductase genes.
Barsoum J; Varshavsky A
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5330-4. PubMed ID: 6351057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
